Sign up to save your podcasts
Or
Share A Look at ACC’s Scientific Statement on Inflammation and CVD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Look at ACC’s Scientific Statement on Inflammation and CVD
In this week’s View, Dr. Eagle looks at an ACC Scientific Statement highlighting inflammation and its role in cardiovascular disease (CVD). He then explores left atrial appendage occlusion (LAAO) in patients with prior intracranial hemorrhage or ischemic stroke. Finally, Dr. Eagle discusses the recently released NEWTON-CABG CardioLink-5 trial on the use of evolocumab in the reduction of saphenous vein graft (SVG) disease rates.
Subscribe to Eagle’s Eye View
View all episodes
By American College of Cardiology
4.7
128128 ratings
In this week’s View, Dr. Eagle looks at an ACC Scientific Statement highlighting inflammation and its role in cardiovascular disease (CVD). He then explores left atrial appendage occlusion (LAAO) in patients with prior intracranial hemorrhage or ischemic stroke. Finally, Dr. Eagle discusses the recently released NEWTON-CABG CardioLink-5 trial on the use of evolocumab in the reduction of saphenous vein graft (SVG) disease rates.
Subscribe to Eagle’s Eye View
More shows like Eagle's Eye View: Your Weekly CV Update From ACC.org
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
319 Listeners
JAMA Clinical Reviews
500 Listeners
JACC This Week
171 Listeners
This Week in Cardiology
883 Listeners
Circulation on the Run
30 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
59 Listeners
ACC CardiaCast
40 Listeners
Annals On Call Podcast
191 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
Mayo Clinic Cardiovascular CME
35 Listeners